Efecto de dosis suprafisiológicas de calcitriol sobre la expresión proteica de células de músculo liso vascular

Autor: Carrillo López N, Tuñón LePoultel D, Quirós Caso C, Rodríguez I, Cannata Andía JB, Naves Díaz M

Publikováno v: Revista de Osteoporosis y Metabolismo Mineral, Vol 9, Iss 4, Pp 130-138 (2017)

Introducción: El calcitriol, fundamental para mantener la homeostasis del calcio y el fósforo en el organismo, puede perjudicar al sistema vascular a dosis elevadas, aumentando el riesgo de calcificación. Objetivo: Evaluar la expresión diferencia

Externí odkaz: https://doaj.org/article/0bee776311e8460bb109a9fabb125b6a

Autor: de Paz Poves C; Laboratorio of Medicina, Departamento de Bioquímica Clinica, Hospital Universitario Central de Asturias, Oviedo, Asturias, España., Barneo-Caragol C; Laboratorio of Medicina, Departamento de Bioquímica Clinica, Hospital Universitario Central de Asturias, Oviedo, Asturias, España., Cillero Sánchez AI; Departamento de Bioquímica Clinica, Hospital Álvarez Buylla, Mieres, Asturias, España., Jiménez Mendiguchia L; Departamento de Bioquímica Clinica, Hospital Universitario San Agustín, Avilés, Asturias, España., Quirós Caso C; Laboratorio of Medicina, Departamento de Bioquímica Clinica, Hospital Universitario Central de Asturias, Oviedo, Asturias, España., Moreno Rodríguez M; Departamento de Bioquímica Clinica, Hospital Universitario San Agustín, Avilés, Asturias, España., López González FJ; Departamento de Neumología, Hospital Universitario Central de Asturias, Oviedo, Asturias, España., Prieto García MB; Laboratorio of Medicina, Departamento de Bioquímica Clinica, Hospital Universitario Central de Asturias, Oviedo, Asturias, España.

Publikováno v: Advances in laboratory medicine [Adv Lab Med] 2023 Dec 04; Vol. 4 (4), pp. 425-430. Date of Electronic Publication: 2023 Dec 04 (Print Publication: 2023).

Baseline immunophenotypic profile of bone marrow leukemia cells in acute myeloid leukemia with nucleophosmin-1 gene mutation: a EuroFlow study.

Autor: Matarraz S; Translational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain. smats@usal.es.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain. smats@usal.es., Leoz P; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain.; Hematology Department, University Hospital of Salamanca, CIBERONC (CB16/12/00233), IBSAL, Accelerator program and Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca), Salamanca, Spain., Yeguas-Bermejo A; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain.; Hematology Department, University Hospital of Salamanca, CIBERONC (CB16/12/00233), IBSAL, Accelerator program and Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca), Salamanca, Spain., van der Velden V; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Bras AE; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Sánchez Gallego JI; Translational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain., Lecrevisse Q; Translational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain., Ayala-Bueno R; Translational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain., Teodosio C; Translational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain., Criado I; Translational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain., González-González M; Translational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain., Flores-Montero J; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain.; Hematology Department, University Hospital of Salamanca, CIBERONC (CB16/12/00233), IBSAL, Accelerator program and Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca), Salamanca, Spain., Avendaño A; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain.; Hematology Department, University Hospital of Salamanca, CIBERONC (CB16/12/00233), IBSAL, Accelerator program and Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca), Salamanca, Spain., Vidriales MB; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain.; Hematology Department, University Hospital of Salamanca, CIBERONC (CB16/12/00233), IBSAL, Accelerator program and Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca), Salamanca, Spain., Chillón MC; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain.; Hematology Department, University Hospital of Salamanca, CIBERONC (CB16/12/00233), IBSAL, Accelerator program and Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca), Salamanca, Spain., González T; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain.; Hematology Department, University Hospital of Salamanca, CIBERONC (CB16/12/00233), IBSAL, Accelerator program and Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca), Salamanca, Spain., García-Sanz R; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain.; Hematology Department, University Hospital of Salamanca, CIBERONC (CB16/12/00233), IBSAL, Accelerator program and Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca), Salamanca, Spain., Prieto Conde MI; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain.; Hematology Department, University Hospital of Salamanca, CIBERONC (CB16/12/00233), IBSAL, Accelerator program and Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca), Salamanca, Spain., Villamor N; Hematology Service, Hospital Clinic, Barcelona, Spain., Magnano L; Hematology Service, Hospital Clinic, Barcelona, Spain., Colado E; Hematology Department and Laboratory Medicine Department, Hospital Universitario Central de Asturias, Oviedo, Spain., Fernández P; FACS/Stem Cell Laboratory, Kantonsspital Aarau, Aarau, Switzerland., Sonneveld E; Dutch Childhood Oncology Group, The Hague, The Netherlands., Philippé J; Department of Diagnostic Sciences, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium., Reiterová M; CLIP-Department of Pediatric Hematology and Oncology, Second Medical Faculty, Charles University and University Hospital Motol, Prague, Czech Republic., Caballero Berrocal JC; Department of Hematology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Diaz-Gálvez FJ; Department of Hematology, Hospital Universitario de Burgos, Burgos, Spain., Ramos F; Department of Hematology, Complejo Asistencial Universitario de León, León, Spain., Dávila Valls J; Department of Hematology, Complejo Asistencial de Ávila, Ávila, Spain., Manjón Sánchez R; Department of Hematology, Complejo Asistencial de Zamora, Zamora, Spain., Solano Tovar J; Department of Hematology, Complejo Asistencial Universitario de Palencia, Palencia, Spain., Calvo X; Pathology Service, Hospital del Mar, Barcelona, Spain., García Alonso L; Hematology Service, University Hospital of Getafe, Madrid, Spain., Arenillas L; Pathology Service, Hospital del Mar, Barcelona, Spain., Alonso S; Hematology Department and Laboratory Medicine Department, Hospital Universitario Central de Asturias, Oviedo, Spain., Fonseca A; Hematology Department and Laboratory Medicine Department, Hospital Universitario Central de Asturias, Oviedo, Spain., Quirós Caso C; Hematology Department and Laboratory Medicine Department, Hospital Universitario Central de Asturias, Oviedo, Spain., van Dongen JJM; Translational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain.; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands., Orfao A; Translational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain. orfao@usal.es.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain. orfao@usal.es.

Publikováno v: Blood cancer journal [Blood Cancer J] 2023 Sep 04; Vol. 13 (1), pp. 132. Date of Electronic Publication: 2023 Sep 04.

Routine flow cytometry approach for the evaluation of solid tumor neoplasms and immune cells in minimally invasive samples.

Autor: Quirós-Caso C; Clinical Biochemistry Department, Hospital Universitario Central de Asturias, Oviedo, Spain.; Laboratory Medicine Department, Hospital Universitario Central de Asturias, Oviedo, Spain., Arias Fernández T; Laboratory Medicine Department, Hospital Universitario Central de Asturias, Oviedo, Spain.; Hematology and Haemotherapy Department, Hospital Universitario Central de Asturias, Oviedo, Spain., Fonseca-Mourelle A; Laboratory Medicine Department, Hospital Universitario Central de Asturias, Oviedo, Spain.; Hematology and Haemotherapy Department, Hospital Universitario Central de Asturias, Oviedo, Spain., Torres H; Surgical Pathology Department, Hospital Universitario Central de Asturias, Oviedo, Spain., Fernández L; Surgical Pathology Department, Hospital Universitario Central de Asturias, Oviedo, Spain., Moreno-Rodríguez M; Clinical Biochemistry Department, Hospital Universitario Central de Asturias, Oviedo, Spain.; Laboratory Medicine Department, Hospital Universitario Central de Asturias, Oviedo, Spain., Ariza-Prota MÁ; Pulmonology Department, Hospital Universitario Central de Asturias, Oviedo, Spain., López-González FJ; Pulmonology Department, Hospital Universitario Central de Asturias, Oviedo, Spain., Carvajal-Álvarez M; Surgical Pathology Department, Hospital Universitario de Cabueñes, Gijón, Spain., Alonso-Álvarez S; Laboratory Medicine Department, Hospital Universitario Central de Asturias, Oviedo, Spain.; Hematology and Haemotherapy Department, Hospital Universitario Central de Asturias, Oviedo, Spain., Moro-García MA; Laboratory Medicine Department, Hospital Universitario Central de Asturias, Oviedo, Spain., Colado E; Laboratory Medicine Department, Hospital Universitario Central de Asturias, Oviedo, Spain.; Hematology and Haemotherapy Department, Hospital Universitario Central de Asturias, Oviedo, Spain.; Instituto Universitario de Oncología del Principado de Asturias.

Publikováno v: Cytometry. Part B, Clinical cytometry [Cytometry B Clin Cytom] 2022 Jul; Vol. 102 (4), pp. 272-282. Date of Electronic Publication: 2022 Jun 15.

Efecto de dosis suprafisiológicas de calcitriol sobre la expresión proteica de células de músculo liso vascular

Autor: Carrillo López, N, Tuñón LePoultel, D, Quirós Caso, C, Rodríguez, I, Cannata Andía, JB, Naves Díaz, M

Publikováno v: Revista de Osteoporosis y Metabolismo Mineral, Volume: 9, Issue: 4, Pages: 130-138, Published: DEC 2017

Resumen Introducción: El calcitriol, fundamental para mantener la homeostasis del calcio y el fósforo en el organismo, puede perjudicar al sistema vascular a dosis elevadas, aumentando el riesgo de calcificación. Objetivo: Evaluar la expresión di

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______624::0611b2c00ee8d2a93a727f80c9b7e7ab
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1889-836X2017000400005&lng=en&tlng=en